Introduction
Rheumatology Therapeutics Market was valued at USD XX Billion in 2019 and is projected to reach USD XX billion by 2025, at a CAGR of XX% from 2020-2025. Rheumatology is the branch of medicine dedicated to diagnosis and rheumatic diseases. Rheumatic diseases are the diseases that affect the supporting and connecting parts of the body such as ligaments, joints, tendons, and rarely some organs of the body. The increasing familiarity Rheumatology Therapeutics globally, the launch of rare therapeutics agents, and favorable refund policies for high-cost treatments are some of the factors responsible for the rapid growth of Rheumatology Therapeutics market. The developing countries are expecting the increased number of diagnosed cases due to improvement in healthcare and diagnostic infrastructure.
This factor is the reason to enable the growth of Rheumatology Therapeutics market during the forecast period. The rising awareness about the rheumatology and its prevention amongst the patients and healthcare professionals are also expected to drive the growth and global market 2019-2025.
Geographical Overview
At a global level, the North America region was holding the highest market share in 2019. Growth witnessed is due to increase familiarity of rheumatology and increasing awareness about the disorder, and increasing healthcare spending. Whereas, Asia Pacific region is considered the fastest-growing region due to increased healthcare infrastructure and increased penetration of rheumatology treatments which gives positive impact in the consumption of rheumatology treatment products. Latin America and Middle East & Africa account for the smaller share of the global rheumatology therapeutics market currently, but is expected to drive the market growth in future due to increasing awareness and undertaking of treatment of rheumatology therapeutics.
Segmental Overview
Rheumatology Therapeutics Market is segmented as per below specifications -
By Product Type:
• Biologics
• Non-Biologics
• NSAIDs
• DMARDs
• Others
By Disease:
• Rheumatoid Arthritis
• Osteoarthritis
• Gout
• Psoriatic Arthritis
• Ankylosing Spondylitis
By Distribution Channel:
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
Competitor Analysis
Rheumatology Therapeutics Market has presence of some of the key major players across globe which includes
• AbbVie Inc.
• Pfizer Inc.
• Bristol-Myers Squibb
• Merck & Co.
• Amgen Inc.
• Janssen Biotech Inc.
• Novartis AG
• Genentech Inc.
• Sanofi S.A.
• Takeda Pharmaceutical
• Celgene Corporation
• Flexion Therapeutics Inc.
These key players are concentratingits efforts on the continuous product improvement with innovative initiatives to have an edge over other competitors. Further, to garner maximum market share,companies are adoptingmerger/ acquisition/ partnership and maintaining strong distribution networks strategies.
By Geographical Locations:
• North America
o U.S.
o Canada
• Europe
o U.K.
o France
o Italy
o Germany
o Spain
o Russia & CIS
o Rest of Europe
• Asia-Pacific
o China
o India
o Japan
o South Korea
o ASEAN
o Rest of Asia Pacific
• Latin America
o Brazil
o Argentina
o Rest of LATAM
• Middle East & Africa
o UAE
o South Africa
o Rest of MEA
Highlights of the report
What is Rheumatology Therapeutics Market?
Who all are key market players in the industry?
How the Parent Industry is growing?
Where are the key opportunities for new market entrant?
A comprehensive analysis, which covers key growth factors across the value chain
Recent developments in market
Granular Market Segmentation
Market size projection based on Historical & current market trends
Market share analysis and key strategies adopted by leadingPlayers
Production Cost & Sensitivity Analysis
Country Level Market Analysis of Top 16 countries
Data Driven Decision Recommendations
Chapter 1 Research Objective
1.1 Need of the Research Report
1.2 Client Objectives
1.3 Offered Solutions
Chapter 2 Recommendations
2.1 Executive Summary
2.1.1 Market Overview
2.1.2 Competitive Insights
2.1.3 Segmental Analysis
2.1.4 Geographical Market Details
2.2 Lead Generation
2.3 Consultant
2.4 Return on Investment
Chapter 3 Research Methodology
3.1 Chromatus Database
3.2 Paid Sources
3.3 Primary Data Collection
3.3.1 Email Surveys
3.3.2 Telephonic Interviews
3.3.3 Face to Face Interviews
3.4 Secondary Data Collection
3.4.1 Annual Reports
3.4.2 Government Publications
3.4.3 Trade Data
3.4.4 Association Data
3.4.5 Research Papers/ Blogs/ News Articles
3.5 Expert Advisory Panel
3.6 Data Analytics Model
Chapter 4 Rheumatology Therapeutics Market Overview
4.1 Parent Market Overview
4.2 Patent Analysis
4.3 PESTEL Analysis
4.3.1 Political
4.3.2 Economical
4.3.3 Social
4.3.4 Technological
4.3.5 Legal
4.4 SWOT Analysis
4.4.1 Strengths
4.4.2 Weakness
4.4.3 Opportunities
4.4.4 Threats
4.5 Regulations
4.6 Value Chain/ Supply Chain Analysis
4.7 Procurement & Vendor Analysis
4.8 Porters Five Analysis
4.8.1 Threat of new entrants
4.8.2 Bargaining power of suppliers
4.8.3 Bargaining power of buyers
4.8.4 Threat of substitutes
4.8.5 Competitive rivalry
Chapter 5 Regional Analysis
Global Rheumatology Therapeutics Market Estimation and Forecast, 2017 - 2025 (USD Billion)
5.1 North America Market
5.1.1 U.S.
5.1.1 Canada
5.2 Europe Market
5.2.1 UK
5.2.2 Germany
5.2.3 France
5.2.4 Spain
5.2.5 Italy
5.2.6 Russia& CIS
5.2.7 Rest of Europe
5.3 Asia Pacific Market
5.3.1 China
5.3.2 Japan
5.3.3 India
5.3.4 South Korea
5.3.5 ASEAN
5.3.6 Rest of Asia Pacific
5.4 Rest of the World
5.4.1 Latin America
5.4.1.1 Brazil
5.4.1.2 Argentina
5.4.1.3 Rest of Latin America
5.4.2 Middle East
5.4.3 Africa
Chapter 6 Company Profile
6.1 AbbVie Inc.
6.1.1 Introduction
6.1.2 Financial Overview
6.1.3 Product Portfolio
6.1.4 Recent Developments
6.1.5 SWOT Analysis
6.2 Pfizer Inc.
6.3 Bristol-Myers Squibb
6.4 Merck & Co.
6.5 Amgen Inc.
6.6 Janssen Biotech Inc.
6.7 Novartis AG
6.8 Genetech Inc.
6.9 Sanofi S.A.
6.10 Takeda Pharmaceutical
6.11 Celgene Corporation
6.12 Flexion Therapeutics Inc.
Chapter 7 Competitor Analysis
7.1 Company Ranking
7.2 Key Innovators
7.3 Market Leader
7.4 Emerging Players
7.5 Strategic Alliances
7.6 Competitive Matrix of 12 Companies
Chapter 8 Global Rheumatology Therapeutics Market by Product Type Estimation and Forecast, 2017 - 2025 (USD Billion)
8.1 Biologics
8.2 Non-Biologics
8.3 NSAIDs
8.4 DMARDs
8.5 Others
Chapter 9 Global Rheumatology Therapeutics Market by Disease Type Estimation and Forecast, 2017 - 2025 (USD Billion)
9.1 Rheumatoid Arthritis
9.2 Osteoarthritis
9.3 Gout
9.4 Psoriatic Arthritis
9.5 Ankylosing Spondylitis
Chapter 10 Global Rheumatology Therapeutics Market by Distribution Channel Estimation and Forecast, 2017 - 2025 (USD Billion)
10.1 Hospital Pharmacy
10.2 Retail Pharmacy
10.3 Online Pharmacy
Chapter 11 Appendix
11.1 Data Sources
11.2 Abbreviations
11.3 About US
11.4 Disclaimer
11.5 Key Notes
List of Tables
Table 1 Global Rheumatology Therapeutics Market, by Region, 2017 - 2025 (USD Billion)
Table2 Global Rheumatology Therapeutics Market, by Product Type, 2017 - 2025 (USD Billion)
Table3 Global Rheumatology Therapeutics Market, by Consumption Type, 2017 - 2025 (USD Billion)
Table4 Global Rheumatology Therapeutics Market, by Distribution Type, 2017 - 2025 (USD Billion)
Table5North America Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table6North America Rheumatology Therapeutics Market by Product Type 2017 - 2025 (USD Billion)
Table7North America Rheumatology Therapeutics Market by Consumption Type 2017 - 2025 (USD Billion)
Table8North America Rheumatology Therapeutics Market by Distribution Type 2017 - 2025 (USD Billion)
Table9US Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table10Canada Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table11Europe Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table12Europe Rheumatology Therapeutics Market by Product Type 2017 - 2025 (USD Billion)
Table13Europe Rheumatology Therapeutics Market by Consumption Type 2017 - 2025 (USD Billion)
Table14Europe Rheumatology Therapeutics Market by Distribution Type 2017 - 2025 (USD Billion)
Table15 UK Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table16GermanyRheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table17France Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table18Spain Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table19ItalyRheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table20Russia& CISRheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table21Rest of Europe Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table22Asia Pacific Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table23Asia Pacific Rheumatology Therapeutics Market by Product Type 2017 - 2025 (USD Billion)
Table24Asia Pacific Rheumatology Therapeutics Market by Consumption Type 2017 - 2025 (USD Billion)
Table25Asia Pacific Rheumatology Therapeutics Market by Distribution Type 2017 - 2025 (USD Billion)
Table26ChinaRheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table27Japan Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table28IndiaRheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table29South Korea Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table30ASEAN Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table31Rest of Asia Pacific Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table32Latin America Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table33Latin America Rheumatology Therapeutics Market by Product Type 2017 - 2025 (USD Billion)
Table34Latin America Rheumatology Therapeutics Market by Consumption Type 2017 - 2025 (USD Billion)
Table35Latin America Rheumatology Therapeutics Market by Distribution Type 2017 - 2025 (USD Billion)
Table36 Brazil Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table37 Argentina Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table38 Rest of Latin America Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table39Middle East Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table40 Middle East Rheumatology Therapeutics Market by Product Type 2017 - 2025 (USD Billion)
Table41Middle East Rheumatology Therapeutics Market by Consumption Type 2017 - 2025 (USD Billion)
Table42Middle East Rheumatology Therapeutics Market by Distribution Type 2017 - 2025 (USD Billion)
Table43Africa Rheumatology Therapeutics Market2017 - 2025 (USD Billion)
Table44 Africa Rheumatology Therapeutics Market by Product Type 2017 - 2025 (USD Billion)
Table45Africa Rheumatology Therapeutics Market by Consumption Type 2017 - 2025 (USD Billion)
Table46Africa Rheumatology Therapeutics Market by Distribution Type 2017 - 2025 (USD Billion)
?
List of Figures
Fig. 1 Primary Research Method
Fig. 2 Secondary Research Method
Fig. 3 Value chain analysis
Fig. 4 PESTEL Analysis
Fig. 5 SWOT Analysis
Fig. 6 Porters Five forces analysis
Fig. 7 Rheumatology Therapeutics Market: Penetration & growth prospect mapping
Fig. 8 Rheumatology Therapeutics Market: Competitive snapshot
Fig. 9 Rheumatology Therapeutics Market: Segmental snapshot
Fig. 10 Market Overview
Fig. 11 Rheumatology Therapeutics Market: Product Analysis, 2017- 2025
Fig. 12 Rheumatology Therapeutics Market: Regional Analysis, 2017- 2025
Fig. 13 Rheumatology Therapeutics Market: Competitive Matrix
Fig. 14 Rheumatology Therapeutics Market: Revenue Mix